Загрузка...
WBRT for brain metastases from non-small cell lung cancer: for whom and when?—Contemporary point of view
The incidence of brain metastases (BM) is estimated between 20% and 40% of patients with solid cancer. The most common cause of this failure is lung cancer, and in locally advanced non-small cell lung cancer (NSCLC) BM represent a common site of relapse in 30–55% cases. The basic criteria of therape...
Сохранить в:
| Опубликовано в: : | J Thorac Dis |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8182552/ https://ncbi.nlm.nih.gov/pubmed/34164217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-2019-rbmlc-06 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|